Catalent Appoints Two New Vice Presidents Of Quality

Catalent Appoints Two New Vice Presidents of Quality

Date: 03/23/2010

Somerset, NJ, March 23, 2010 — Catalent Pharma Solutions, Inc. announced the appointments of Lois Johnson to the position of Vice President of Quality, Development and Clinical Services, and Alex Eslava as Vice President of Quality, Sterile Technologies. Ms. Johnson and Dr. Eslava will be based in Somerset, NJ.

Ms. Johnson is a Quality professional with more than 20 years of experience in the biopharmaceutical/biotech industry, and has worked in both commercial and R&D areas during her career. Prior to joining Catalent, Ms. Johnson was Senior Director of Quality Assurance-North America for Aptuit, Inc. There, she led a team that managed all quality and regulatory activities and processes, from product conception through commercial manufacture. Prior to Aptuit, Ms. Johnson held Quality leadership positions at Vertex Pharmaceuticals, Aventis Behring Corporation, Centeon and Rhone-Poulenc Rorer (both formerly part of Armour Pharmaceutical), and Armour Pharmaceutical.

Ms. Johnson holds a Master of Product Development from Northwestern University and a B.S. in Biology from Roosevelt University in Chicago, IL.

Dr. Eslava joins Catalent from Wyeth, where he was Assistant Vice President and Quality Head for the company’s Biotechnology area. In that role, he directed an organization of 300 employees and was responsible for the chemical/biochemical and microbiology laboratories; in-process and final production inspections; quality engineering; supplier evaluations; internal and external audits; and product releases. Prior to that position, Dr. Eslava was Assistant Vice President of quality for Wyeth’s Latin America business. Before joining Wyeth, he was Director of Quality for AMGEN in Puerto Rico. Earlier in his career, Dr. Eslava held several Quality leadership positions with Baxter Healthcare at their Puerto Rico, Colombia, and Illinois facilities.

Dr. Eslava holds a Ph.D. in Physical Chemistry and Master of Science degree in Physical Chemistry, both from Princeton University. He has a B.S. in Chemistry from Louisiana State University. He also did a post-doctoral Fellowship at The Hebrew University in Israel.

“I am very pleased to have Lois and Alex on the Catalent Quality and Regulatory team,” said Sharon Johnson, Senior Vice President, Global Quality and Regulatory Affairs. “Each of them brings a strong functional background, record of achievement, and business acumen that I know will enable them to contribute greatly to Catalent’s approach to quality excellence.”

About Catalent

Headquartered in Somerset, New Jersey, Catalent Pharma Solutions is a leading provider of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,100 people at 30 facilities worldwide and in fiscal 2009 generated more than $1.6 billion in annual revenue. For more information, visit .

more products. better treatments. reliably supplied.™